ReviewFrontiers in drug safety and regulation2025

Discrepancies in regulations in post-marketing safety surveillance of drug-device combination products in the EU and US: a review.

Joan D'souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.